Economic Times · Stocks
Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr
Published by Economic Times on IST
Glenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from operations decreased to Rs 4,247.32 crore compared to the previous year. The company's total expenses also decreased during the same period, indicating some operational…
Read the full story on Economic Times ↗This summary is from Economic Times’s own news feed. The full article, and the rights to it, belong to Economic Times.
